Concepedia

Jeff S. Isenberg

JS

32

Publications

3K

Citations

26

H-Index

1998

Active since

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Center for Cancer Research

Washington University in St. Louis

University of Pittsburgh

Jeff S. Isenberg is an author at National Institutes of Health specializing in medicine, vascular biology, and cell biology.

Top concepts

Publications per year

1998–2011

32

Publications

32

CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1

Jeff S. Isenberg, Lisa A. Ridnour, Julie Dimitry et al. · Journal of Biological Chemistry · 2006 · 279 citations · Full text

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner

Jeff S. Isenberg, Lisa A. Ridnour, Elizabeth M. Perruccio et al. · Proceedings of the National Academy of Sciences · 2005 · 269 citations · Full text

, , +19

Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47

Sukhbir Kaur, Gema Martin‐Manso, Michael L. Pendrak et al. · Journal of Biological Chemistry · 2010 · 221 citations · Full text

, , +17

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

Jeff S. Isenberg, Martin J. Romeo, Christine Yu et al. · Blood · 2007 · 197 citations · Full text

Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling

Justin B. Maxhimer, David R. Soto‐Pantoja, Lisa A. Ridnour et al. · Science Translational Medicine · 2009 · 179 citations · Full text

, , +17

Rows per page

1–5 of 32